Clinical Risk Grouping Solution Market Research Report by Product (Dashboard Analytics Solutions, Risk Reporting Solutions, and Scorecards & Visualization Tools), by Deployment Mode (Private Cloud and Public Cloud), by End User, by State (California, Flor

Clinical Risk Grouping Solution Market Research Report by Product (Dashboard Analytics Solutions, Risk Reporting Solutions, and Scorecards & Visualization Tools), by Deployment Mode (Private Cloud and Public Cloud), by End User, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States Clinical Risk Grouping Solution Market size was estimated at USD 122.12 million in 2020 and expected to reach USD 145.85 million in 2021, at a CAGR 16.51% to reach USD 305.62 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Clinical Risk Grouping Solution to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Dashboard Analytics Solutions, Risk Reporting Solutions, and Scorecards & Visualization Tools.

Based on Deployment Mode, the market was studied across Private Cloud and Public Cloud.

Based on End User, the market was studied across Ambulatory Care Centers, Hospitals, Long-Term Care Centers, and Payers.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Risk Grouping Solution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Clinical Risk Grouping Solution Market, including 3M Company, 4S Information Systems Ltd., Cerner Corporation, Conduent Incorporated, Dynamic Healthcare Systems, Inc., Evolent Health, HBI Solutions, Inc., Health Catalyst Inc., Johns Hopkins University, Lightbeam Health Solutions, LLC, Nuance Communications, Optum Inc., and Perahealth, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Clinical Risk Grouping Solution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Clinical Risk Grouping Solution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Clinical Risk Grouping Solution Market?
4. What is the competitive strategic window for opportunities in the United States Clinical Risk Grouping Solution Market?
5. What are the technology trends and regulatory frameworks in the United States Clinical Risk Grouping Solution Market?
6. What is the market share of the leading vendors in the United States Clinical Risk Grouping Solution Market?
7. What modes and strategic moves are considered suitable for entering the United States Clinical Risk Grouping Solution Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Clinical Risk Grouping Solution Market, by Product
6.1. Introduction
6.2. Dashboard Analytics Solutions
6.3. Risk Reporting Solutions
6.4. Scorecards & Visualization Tools
7. Clinical Risk Grouping Solution Market, by Deployment Mode
7.1. Introduction
7.2. Private Cloud
7.3. Public Cloud
8. Clinical Risk Grouping Solution Market, by End User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Hospitals
8.4. Long-Term Care Centers
8.5. Payers
9. California Clinical Risk Grouping Solution Market
10. Florida Clinical Risk Grouping Solution Market
11. Illinois Clinical Risk Grouping Solution Market
12. New York Clinical Risk Grouping Solution Market
13. Ohio Clinical Risk Grouping Solution Market
14. Pennsylvania Clinical Risk Grouping Solution Market
15. Texas Clinical Risk Grouping Solution Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. 3M Company
17.2. 4S Information Systems Ltd.
17.3. Cerner Corporation
17.4. Conduent Incorporated
17.5. Dynamic Healthcare Systems, Inc.
17.6. Evolent Health
17.7. HBI Solutions, Inc.
17.8. Health Catalyst Inc.
17.9. Johns Hopkins University
17.10. Lightbeam Health Solutions, LLC
17.11. Nuance Communications
17.12. Optum Inc.
17.13. Perahealth, Inc.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DASHBOARD ANALYTICS SOLUTIONS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DASHBOARD ANALYTICS SOLUTIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK REPORTING SOLUTIONS, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK REPORTING SOLUTIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SCORECARDS & VISUALIZATION TOOLS, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SCORECARDS & VISUALIZATION TOOLS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2020 VS 2026 (%)
FIGURE 14. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2026
FIGURE 16. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 21. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2026
FIGURE 23. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY AMBULATORY CARE CENTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LONG-TERM CARE CENTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: FPNV POSITIONING MATRIX
FIGURE 32. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 33. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DASHBOARD ANALYTICS SOLUTIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK REPORTING SOLUTIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SCORECARDS & VISUALIZATION TOOLS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY AMBULATORY CARE CENTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LONG-TERM CARE CENTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: SCORES
TABLE 17. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: BUSINESS STRATEGY
TABLE 18. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: PRODUCT SATISFACTION
TABLE 19. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: RANKING
TABLE 20. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 21. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: MERGER & ACQUISITION
TABLE 22. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 23. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 24. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: INVESTMENT & FUNDING
TABLE 25. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 26. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook